By analysing 170 clinical gastric cancer patients, we concluded that high expression of SDPR or low expression of CPT1A in gastric cancer patients was associated with better overall survival (OS), interestingly, patients with both high expression of SDPR and low expression of CPT1A had the best prognosis (Figure 7C). Here, CPT1A is linked to gastric cancer.